Challenges for the Development of Bone-Forming Agents in Europe

Sclerostin Inhibition for Osteoporosis — A New Approach

(2014) Carolyn B. Becker   NEW ENGLAND JOURNAL OF MEDICINE

Romosozumab in Postmenopausal Women with Low Bone Mineral Density

(2014) Michael R. McClung et al.   NEW ENGLAND JOURNAL OF MEDICINE

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

(2012) S. Lekamwasam et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

A systematic review of hip fracture incidence and probability of fracture worldwide

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

FRAX® with and without Bone Mineral Density

(2011) John A. Kanis et al.   CALCIFIED TISSUE INTERNATIONAL

Osteoporosis: burden, health care provision and opportunities in the EU

(2011) O. Ström et al.   Archives of Osteoporosis

Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women

(2009) Dana Bliuc   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL